Nabsys: Funding, Investors & Team (Oct 2026)
Using specialized electronic nano-channel detectors, Nabsys analyzes lengthy DNA molecules quickly. Nabsys is able to produce a resolution that is substantially higher than what is possible using optical mapping techniques. Whole genome maps are created by Nabsys HD-MappingTM solid-state electronic nano-channel detectors at sub-diffraction-limit resolution. These maps provide significant benefits for assembling genomes, analyzing structural variation, and verifying putative variants identified by other technologies. Long DNA molecules are given sequence-specific tags via HD-Mapping. These molecules are controlled via electrophoretic and hydrodynamic control to go through the nano-detectors at high speed. The detectors provide information about where the molecules' sequence-specific tags are located. After that, Nabsys analytical software analyzes the data.
Nabsys has raised $38.0M across 2 funding rounds on record, the most recent an undisclosed round of $13.0M announced in Nov 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Nabsys Company Profile and Key Stats
Latest funding round on record: Nov 2022.
Nabsys Funding Rounds
Nabsys raised $25.0M in a Corporate Round announced in Apr 2022.
7 months later, an undisclosed round of $13.0M was announced in Nov 2022.
Nabsys Founders and Leadership Team
Contact details for the Nabsys team: 1 of 1 has an email address on file.
Start 14-day free trial →Nabsys Funding Compared to Other Biotechnology Startups
Nabsys' latest round of $13.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Nabsys in Biotechnology and Providence
Companies Similar to Nabsys
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Nabsys Funding FAQs
What does Nabsys do?
Using specialized electronic nano-channel detectors, Nabsys analyzes lengthy DNA molecules quickly. Nabsys is able to produce a resolution that is substantially higher than what is possible using optical mapping techniques. Whole genome maps are created by Nabsys HD-MappingTM solid-state electronic nano-channel detectors at sub-diffraction-limit resolution. These maps provide significant benefits for assembling genomes, analyzing structural variation, and verifying putative variants identified by other technologies. Long DNA molecules are given sequence-specific tags via HD-Mapping. These molecules are controlled via electrophoretic and hydrodynamic control to go through the nano-detectors at high speed. The detectors provide information about where the molecules' sequence-specific tags are located. After that, Nabsys analytical software analyzes the data.
How much funding has Nabsys raised?
Nabsys has raised $38.0M across 2 rounds on record. The most recent is an undisclosed round of $13.0M announced in Nov 2022.
When did Nabsys last raise funding?
Nabsys' most recent funding round on record is an undisclosed round of $13.0M, announced in Nov 2022.
Who is the CEO of Nabsys?
Barrett Bready is listed as CEO at Nabsys.
Where is Nabsys headquartered?
Nabsys is based in Providence, Rhode Island, United States.
How many employees does Nabsys have?
Nabsys is in the 11-50 employee band.
How does Nabsys' funding compare to other Biotechnology startups?
Nabsys' latest round of $13.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Nabsys Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Nabsys is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.